The $ 38 billion US commercial weight loss market is 15% higher than in 2020, but it had to turn to adapt to the huge competition of popular GLP-1 drugs.
$38.4 Billion U.S. Commercial Weight Loss Market Pivots to Survive GLP-1 Drugs Explosion
Explosion